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Neurodegenerative diseases involve the progressive deterioration of structures within
the central nervous system responsible for motor control, cognition, and autonomic
function. Alzheimer’s disease and Parkinson’s disease are among the most common
neurodegenerative disease and have an increasing prevalence over the age of 50.
Central in the pathophysiology of these neurodegenerative diseases is the loss of
protein homeostasis, resulting in misfolding and aggregation of damaged proteins. An
element of the protein homeostasis network that prevents the dysregulation associated
with neurodegeneration is the role of molecular chaperones. Heat shock proteins
(HSPs) are chaperones that regulate the aggregation and disaggregation of proteins
in intracellular and extracellular spaces, and evidence supports their protective effect
against protein aggregation common to neurodegenerative diseases. Consequently,
upregulation of HSPs, such as HSP70, may be a target for therapeutic intervention
for protection against neurodegeneration. A novel therapeutic intervention to increase
the expression of HSP may be found in heat therapy and/or heat acclimation. In
healthy populations, these interventions have been shown to increase HSP expression.
Elevated HSP may have central therapeutic effects, preventing or reducing the toxicity
of protein aggregation, and/or peripherally by enhancing neuromuscular function.
Broader physiological responses to heat therapy have also been identified and include
improvements in muscle function, cerebral blood flow, and markers of metabolic health.
These outcomes may also have a significant benefit for people with neurodegenerative
disease. While there is limited research into body warming in patient populations,
regular passive heating (sauna bathing) has been associated with a reduced risk of
developing neurodegenerative disease. Therefore, the emerging evidence is compelling
and warrants further investigation of the potential benefits of heat acclimation and
passive heat therapy for sufferers of neurodegenerative diseases.
Keywords: neurodegenerative disease, heat shock protein, passive heating, thermal therapy, body warming,
alpha-synuclein
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INTRODUCTION
Humans are homeothermic and as such regulate their core
body temperature within a narrow range. Perturbations to this
homeostasis, induced by external environmental thermal stress
or internally generated metabolic heat, produces both autonomic
and behavioral responses designed to elicit a return of core
body temperature toward thermal balance (Schlader and Vargas,
2019). While in an acute sense this stress response is a defense
mechanism, regularly challenging the thermal equilibrium via
active or passive thermal stress results in positive physiological
and perceptual adaptations (Tyler et al., 2016). Recent research
has shown positive therapeutic effects of passive heating for
people with peripheral arterial disease (Neff et al., 2016; Akerman
et al., 2019), chronic heart failure (Kihara et al., 2002; Ohori
et al., 2012), diabetes (Hooper, 1999), and depression (Janssen
et al., 2016). Passive heating also improves a range of health
markers, including cardiovascular health indices, such as vascular
function, blood pressure, and arterial stiffness (Brunt et al.,
2016a,b), as well as metabolic health and glycemic control
(Janssen et al., 2016; Kimball et al., 2018; Ely et al., 2019; Maley
et al., 2019). Several mechanistic pathways may underpin these
adaptations, including improved cellular respiration (Hafen et al.,
2018), circulating factors (Brunt et al., 2019), and vascular shear
stress (Tinken et al., 2009; Thomas et al., 2016). The upregulation
of heat shock proteins (HSPs) as a result of acute and/or
chronic (repeated) exposure to passive heating is also an adaptive
outcome, which may provide a specific mechanistic pathway for
improving health and function within the body (Faulkner et al.,
2017; Brunt et al., 2018).
Recent reviews have identified the upregulation of HSPs
as therapeutic targets for the treatment of neurodegenerative
diseases including Parkinson’s disease and Alzheimer’s disease
(Carman et al., 2013; Kalmar et al., 2014; Schapira et al., 2014;
Ciechanover and Kwon, 2017; Webster et al., 2017; Klaips
et al., 2018). Neurodegenerative diseases are characterized by
the progressive deterioration of structures within the central
nervous system responsible for motor control, cognition, and
autonomic function. Alzheimer’s and Parkinson’s diseases are
among the most common neurodegenerative diseases and have
an increasing prevalence over the age of 50 (Pringsheim et al.,
2014). Loss of protein homeostasis, due to protein mis-folding
and aggregation of damaged proteins, is a hallmark of both
Alzheimer’s and Parkinson’s diseases (Labbadia and Morimoto,
2015). HSPs function as chaperones to ensure appropriate cell
function with distinct roles in the unfolded protein response,
recognizing misfolded or mis-localized proteins that may be
subsequently degraded by the proteasome, and are a key
component of chaperone-mediated autophagy (Adachi et al.,
2009; Stetler et al., 2010; Leak, 2014; Zarouchlioti et al., 2018). For
their role in regulating protein homeostasis, HSP expression has
been proposed as a therapeutic target for the treatment of these
neurodegenerative diseases (Carman et al., 2013; Kalmar et al.,
2014; Schapira et al., 2014; Ciechanover and Kwon, 2017; Webster
et al., 2017; Klaips et al., 2018).
As physical and cognitive ability decline in Alzheimer’s and
Parkinson’s diseases, passive heat therapy may yield an achievable
alternative to the presently recommended exercise interventions
in this population. Intriguingly, the incidence of Alzheimer’s
disease has recently been shown to be reduced in people who
undertook moderate to frequent sauna bathing (Laukkanen
et al., 2017). While the current evidence for heat therapy in
neurodegenerative disease is associative and the mechanisms by
which improved health outcomes are achieved have yet to be
elucidated, the potential of passive heating in this population
remains an alluring therapeutic option.
This review will examine pathophysiological determinants of
common neurodegenerative disease, examine the evidence of an
elevated HSP expression as a potential therapeutic intervention
in common neurodegenerative diseases, and describe the role
heat acclimation and passive heat therapy have in inducing HSP
expression. In addition, central and peripheral adaptations to
body warming in healthy adults, including improved muscular
function, cerebral blood flow, and metabolic health, will be
considered with their potential influence on neurodegenerative
disease outcomes. Finally, considerations for undertaking heat
acclimation and/or passive heating interventions in people with
neurodegenerative diseases will be addressed.
NEURODEGENERATIVE DISEASES
Epidemiology and Pathophysiology
Central in the pathophysiology of neurodegenerative diseases
is the loss of protein homeostasis and the progressive loss
of selective neurons. Protein homeostasis involves a complex
system of protein synthesis, folding, disaggregation, and
degradation that ensures the correct function of the human
body and particularly the central nervous system (Klaips
et al., 2018). Loss of protein homeostasis, due to protein mis-
folding and aggregation of damaged proteins, is a hallmark of
neurodegenerative diseases such as Alzheimer’s and Parkinson’s
diseases (Labbadia and Morimoto, 2015). Alzheimer’s and
Parkinson’s are the two most common degenerative neurological
conditions and are more prevalent with advancing age.
Both of these neurodegenerative diseases are progressive with
pathological features demonstrating topographic distribution.
The progressive loss of selective neurons includes amyloidosis,
tauopathies, alpha-synucleinopathies, and proteinopathies, all of
which have their own characteristic histopathological imaging
features, as well as clinical symptomology. The diseases are
incurable and result in long-term cognitive, psychological, motor,
and non-motor impairments that have a profound impact
on functional mobility, psychological well-being, independent
living, and quality of life.
Alzheimer’s Disease
Alzheimer’s disease is the most prevalent neurodegenerative
disease and is the most common form of dementia (Thies and
Bleiler, 2012), which affects 40–50 million people worldwide
(Prince et al., 2013; Nichols et al., 2019). Early stages of
Alzheimer’s presents with mild cognitive impairment involving
memory loss and progresses with deficits in attention,
language, and visuospatial abilities (Galton et al., 2000;
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Wattmo et al., 2016). Social withdrawal accompanies disease
progression, as symptoms include a reduced capacity to perform
activates of daily living, impaired executive function and
judgment, along with disorientation (Wattmo et al., 2016). These
outcomes have a significant impact on independence, quality
of life, and years of life with a disability (Martyr et al., 2019).
Furthermore, the economic cost of dementia is $968 billion
globally (Xu et al., 2017). These costs are born by individuals
and their caregivers, social health services, as well as public and
private health care providers (Castro et al., 2010). Due to the
aging population, the prevalence and impact of Alzheimer’s
disease are anticipated to increase in the future (Prince et al.,
2013; Nichols et al., 2019).
Neurodegenerative diseases such as Alzheimer’s are marked by
a loss of cellular protein homeostasis (Ciechanover and Kwon,
2017; Klaips et al., 2018). The pathophysiology of Alzheimer’s is
evidenced by intracellular and extracellular amyloid-β plaques
as well as neurofibrillary tangles of hyperphosphorylated
tau (Montine et al., 2012; Ciechanover and Kwon, 2017).
Neurodegeneration occurs as a result of the accumulation of
tau proteins and atrophy of cerebral cortices. Amyloid deposits
occur in the neocortex and hippocampus (Phases 1 and 2),
the striatum (Phase 3), the brainstem (Phase 4), and the
cerebellum (Phase 5) (Montine et al., 2012). In concert with
abnormal protein accumulation, the pathogenesis of Alzheimer’s
disease may also involve vascular impairments leading to chronic
cerebral hypoperfusion (de la Torre, 2004; Akinyemi et al.,
2013; Sweeney et al., 2018). To combat these pathophysiological
progressions, therapeutic interventions to improve protein
quality control and regulation or improve vascular health
and function have been recommended (Akinyemi et al., 2013;
Ciechanover and Kwon, 2017).
Parkinson’s Disease
Parkinson’s disease is the second most common
neurodegenerative disease, after Alzheimer’s disease.
For Parkinson’s disease, the progressive degeneration of
dopaminergic neurons in the substantia nigra pars compacta
results in severe motor (e.g., tremor, rigidity, bradykinesia,
postural instability) and non-motor symptoms (e.g., sleep
disturbances, apathy, cognitive dysfunction, anxiety, depression)
(Politis et al., 2010; Asahina et al., 2013). Both motor and
non-motor impairments contribute to reduced physical activity
and consequently decreased fitness in people with Parkinson’s
disease (Speelman et al., 2011). This decreased fitness exacerbates
both pre-existing and disease-specific conditions including
cardiovascular disease, muscle weakness, postural instability,
osteoporosis, sleep disruption, impaired cognitive function,
depression and constipation (Speelman et al., 2011). Estimates
suggest that Parkinson’s disease affects between 5 and 7
million people worldwide (Dorsey et al., 2018). The annual
economic cost of Parkinson’s disease is estimated to be £3.3
billion in the United Kingdom (Findley, 2007), $23 billion
in the United States (Findley, 2007), $6.3 billion in Australia
(Access Economics (Firm) and Parkinson’s Australia, 2007).
The degradation in neural function in Parkinson’s disease
is evidenced by degeneration of substantia nigral neurons,
accumulation of alpha-synuclein and Lewy bodies, cortical
atrophy and alteration in neural oscillatory activity between
basal ganglia, thalamus, cortex, and brainstem areas. It has been
proposed by Braak et al. (2003) that in Parkinson’s disease,
the topographic progress of neurodegeneration, follows patterns
of alpha-synuclein aggregation expressed in Lewy neurites and
Lewy bodies. This occurs first in the medulla and olfactory bulb,
then progressively dorsally through the brainstem, mediobasal
forebrain, limbic structures, higher-order sensory association and
prefrontal areas, and finally to primary sensory and motor areas
(Braak et al., 2003). A central tenet of this proposal is that the
initial disease onset is a result of inflammatory processes in the
enteric system that result in progression to the central nervous
system via the vagal nerve (Breen et al., 2019). Additionally,
deterioration in the vasculature of the brain resulting in abnormal
cerebral perfusion patterns has been identified in people with
Parkinson’s disease, suggesting a role of cerebral blood flow in the
pathophysiology of the disease (Melzer et al., 2011; Syrimi et al.,
2017; Sweeney et al., 2018).
Heat Shock Proteins as a Therapeutic
Target
Recent reviews have clearly identified the upregulation of HSPs
as thermally activated therapeutic targets for the treatment
of neurodegenerative diseases including Parkinson’s and
Alzheimer’s (Carman et al., 2013; Kalmar et al., 2014; Schapira
et al., 2014; Ciechanover and Kwon, 2017; Webster et al.,
2017; Klaips et al., 2018). HSPs are a collective family of
proteins, suffixed by their molecular weight (in kilodaltons;
kDa), which are present in both constitutively expressed, and
inducible isoforms across several intracellular tissue sites and
in extracellular fluid following stress (Kampinga et al., 2009).
Relative to increased intracellular HSP content (a necessary
component for protective cellular adaptation), the presence
of extracellular changes in HSP concentration reflects a less
pertinent (in the context of adaptation) transient stress response
which acts as an acute signaling response. The 70 kDa (HSPA)
and 90 kDa (HSPC) family of HSPs, hereafter referred to
as HSP70 and HSP90, are generally the most widely studied
responders to thermal stressors and are likely of most relevance
within the field of heat therapy and heat adaptation for
neurodegenerative disease (Luo et al., 2010; Fontaine et al., 2016;
Lackie et al., 2017). HSP70 and HSP90 function as chaperones
to ensure appropriate cell function and have distinct roles in
the unfolded protein response, e.g., recognizing misfolded or
mis-localized proteins that may be subsequently degraded by the
proteasome, and are a key component of chaperone-mediated
autophagy (Adachi et al., 2009; Stetler et al., 2010; Leak, 2014;
Kampinga and Bergink, 2016; Zarouchlioti et al., 2018). It is
outside of the focus of this review to describe each of these roles,
with the reader directed elsewhere to contextualize these actions
(Adachi et al., 2009; Stetler et al., 2010; Leak, 2014; Kampinga
and Bergink, 2016; Zarouchlioti et al., 2018).
As therapeutic targets, HSP70 and HSP90 may be considered
to have a direct and indirect role in neurodegenerative
diseases. Direct roles for HSPs on the nervous system arise
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from the aforementioned notion that aggregation of misfolded
proteins is characteristic of neurodegenerative diseases, including
Parkinson’s, Alzheimer’s, and Huntington’s (Stetler et al., 2010).
In Parkinson’s, HSP70 is reported as being of decreased gene
expression (Mandel et al., 2005), while during proteomic
profiling, reduced phosphorylation of HSP90 is also reported
(Kulathingal et al., 2009). Pharmacological and animal models
utilizing HSP expression (elevated HSP70 and reduced HSP90)
have reduced the aggregation and toxicity of alpha-synuclein
in Parkinson’s disease (Auluck et al., 2002; Klucken et al.,
2004; Danzer et al., 2011; Gao et al., 2015). In Alzheimer’s,
HSP70 may suppress the proteolysis of amyloid precursor protein
(Hoshino et al., 2007) and in addition to HSP70, HSP90, and
small HSPs reduce the formation of A-beta fibrils (Kudva et al.,
1997; Lee et al., 2005; Wilhelmus et al., 2006a) and A-beta
toxicity (Wilhelmus et al., 2006b) which subsequently form
amyloid plaques. Tauopathy occurrence in Alzheimer’s may also
be positively impacted by HSP changes with HSP70 (Jinwal
et al., 2009) and HSP90 (Evans et al., 2006; Luo et al., 2007).
Further, HSPs have been found to regulate huntingtin via reduced
cell aggregation in Huntington’s disease (Muchowski et al.,
2000; Sittler et al., 2001), and slows the muscle denervation of
amyotrophic lateral sclerosis (Motor Neuron Disease) (Kieran
et al., 2004; Kalmar et al., 2008, 2012).
Much of the literature describing these responses involve
complex and isolated tissue/cell models to understand how HSP
manipulation impacts upon neurodegenerative disease factors,
thus direct application for humans remains unknown. However,
with mechanistic support for the role of HSP augmentation to
improve disease states, the application of heat therapy and/or
heat adaptation in this context warrants further investigation.
RESPONSES TO ACTIVE (EXERCISE
HEAT ACCLIMATION) AND PASSIVE
HEAT THERAPY IN HEALTHY ADULTS
Physical activity and exercise have long been identified as
mechanisms of inducing physiological stressors and subsequent
positive adaptations in healthy (Tyler et al., 2016) and chronic
disease (Hoffmann et al., 2016) populations. Unfortunately,
those with increasing disease severity or diseases that challenge
their motor control capabilities may be physically incapable
of performing such beneficial exercise. Heat therapy has
recently been targeted as a potential vehicle to evoke these
positive thermal-induced adaptations in those precluded from
undertaking exercise. Experimental investigations, large cohort
surveys and reviews have expressed the potential for passive
heating to improve physical and mental health in patients
with cardiovascular disease (Brunt et al., 2016a,b; Maeda et al.,
2018), diabetes (Kimball et al., 2018; Maley et al., 2019),
peripheral arterial disease (Akerman et al., 2019), and depression
(Janssen et al., 2016).
While there is a myriad of beneficial physiological and
molecular effects of active and passive heating, this review will
primarily focus specifically on the outcome of HSP expression,
for its potential to influence proteostasis in neurodegenerative
disease. For active and passive heating to be effective in increasing
HSP expression, the minimum exposure requirements to elicit
a desirable response in HSPs, from both acute and chronic
(repeated) exposure, needs to be identified.
Acute Effects of Body Warming on Heat
Shock Proteins
Transcription of HSP mRNA, an essential step before protein
translation, is primarily regulated by Heat shock factor protein
1 (HSF-1) as part of the Heat Shock Response (Kregel, 2002).
HSF-1 activation involves a complex series of regulatory events,
including nuclear localization, oligomerization and acquisition
of HSE–DNA binding, ultimately resulting in the transcription
of HSP mRNA (Sarge et al., 1993) in response to the thermal
and physiological challenge (McClung et al., 2008; Maloyan et al.,
2011). Sufficient mRNA transcription then leads to increased
protein within the stressed cell.
Precise parameters for intracellular increases, and thus cellular
adaptation, have been less clearly defined. For example, mean
core body temperature may not be the sole marker of an increase,
rather the rate of change in core body temperature may be
of greater importance to signal HSF-1 to HSP70 pathways. In
the more common exercise-heat stress model, a recent analysis
concluded that when transcription of the related HSP70 and
HSP90α mRNA is important, protocols should rapidly induce
large, prolonged changes in core body temperature (Gibson
et al., 2016). This notion was supported by evidence that,
when analyzed collectively, significant predictors of the post-
exercise change in HSP70 and HSP90α mRNA were the change
in mean and peak core body temperature, and the duration
core body temperature was ≥38.5◦C (Gibson et al., 2016). It
should be acknowledged that these data describe responses
to exercise-heat stress, an intervention that is likely to be
challenging to implement in clinical populations. Accordingly,
passive heating via body warming may prove to be a more
efficacious intervention.
The HSP response to localized or whole body warming has
also been investigated. In passive heating models, increases in
HSP70 and HSP90 mRNA have been evidenced as peaking
30 min following 90 min of local heating to either the thigh
or the whole leg of healthy human volunteers (Kuhlenhoelter
et al., 2016). Regrettably, no intramuscular temperature data
is available from this experiment to assist with identifying
minimum exposure requirement. This increase following resting,
local heat stress which does not alter core body temperature
offers mechanistic insight as elevations in blood flow and
shear stress provide a non-core body temperature dependent
HSP response that parallels transcription of angiogenic markers
(Kuhlenhoelter et al., 2016). Not all experimental work has
observed changes in HSP following passive heating. Leg
immersion in hot water at 45◦C for 60 min, eliciting an
increased intramuscular temperature of >39◦C, did not affect
muscle HSPs (HSP70, HSC70, HSP60, HSP27, alphaB-crystallin)
in healthy young humans (Morton et al., 2007). It should be
noted that this null-observation came 48 h following, rather
than immediately after heating, which may provide a rationale
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for the response. These data share commonality with responses
observed elsewhere in relation to HSP70 and HSP27 stasis
24 h following ∼80 min of heating at ∼49◦C (Vardiman et al.,
2013) to increase intramuscular temperature also to >39◦C,
suggesting that the dose of heat therapy may be an important
driver of HSP response or that the inconsistent timing of
differential tissue sampling are experimental artifacts impacting
current understanding.
Examination of extracellular changes in HSP70 during
acute exercise-heat stress in humans has identified that the
endogenous requirement for extracellular HSP70 release (at
the cessation of exercise) may be a core body temperature
mean of >38.5◦C (peak of 39.2◦C) for 56 min, alongside
moderate exercising intensities (Gibson et al., 2014). Although
changes may occur more rapidly (within 27 min) if exercise
intensities are higher (Périard et al., 2012). Both the change
in and final core body temperature attained are relevant
to extracellular HSP70 release (Périard et al., 2012) and
indicate achieving substantial elevations in thermal parameters
is important when administering exercise-heat exposures to
increase thermotolerance in whole-body models.
Chronic Effects of Body Warming on
Heat Shock Proteins
The HSP responses to exercise-heat acclimation have been
reviewed previously, with an acknowledgment that the
intervention is an effective means to augment cellular
thermotolerance, which may subsequently protect vital organs
from deleterious effects of heat stress in humans (Amorim
et al., 2015). An internal temperature threshold for intracellular
HSP70 induction may exist, though it is also possible that this
response occurs once a certain variation of internal, whole-
body temperature is reached alongside additional stressors
(Magalhães et al., 2010). For example, during a 10-day heat
acclimation period, Magalhães et al. (2010) demonstrated the
largest changes in post-exercise intracellular HSP70 when a
core body temperature >39.0◦C was achieved. In contrast,
Yamada et al. (2007) and Hom et al. (2012) reported no
change in HSP70 in response to a lower core body temperature
(mean maximum of ∼38.5◦C) following 10 days of heat
acclimation. HSP70 and HSP90 mRNA transcription occur at
a series of core body temperature thresholds during 90 min
of exercise-heat stress (mean 37.6–38.2◦C; peak 38.1–39.1◦C)
(Gibson et al., 2015a,b) therefore the dose of heat stress
to elicit translation may be greater than that required to
elicit transcription.
In human whole-body passive heating models, such as hot
water immersion of >60 min whereby core body temperature
is increased, higher extracellular HSP70 concentration (Faulkner
et al., 2017), and intracellular HSP70 changes (Oehler et al.,
2001), have been reported. The beneficial response once again is
not unanimous, with others reporting chronic change (following
2 weeks of repeated therapy) in intracellular HSP70 after 45–
60 min of passive heat therapy (Hoekstra et al., 2018). In a similar
manner to that described for local heating, the dose of stress may
be important given the lack of change in studies using 60 min
heating (Hoekstra et al., 2018), in comparison to those who do
report an acute increase in intracellular HSP70 following 120 min
heating in 39◦C water (Oehler et al., 2001).
Intracellular HSP70 and HSP90 levels in peripheral blood
mononuclear cells (PBMC) are increased after 6–10 days of
long term exercise-heat acclimation (Yamada et al., 2007;
McClung et al., 2008). The two larger HSPs appear to
be related with regards to exercise-heat stress changes, as
an HSP70 increase of ∼21% was correlated with HSP90
increases of ∼18% (McClung et al., 2008). In vitro analysis
of PBMC obtained from 10-day exercise-heat acclimated
individuals exhibit greater blunting of the HSP response to
heat shock of 43◦C for 60 min (compared to unacclimated).
This blunted pre-post response is indicative of increased
thermotolerance and/or cellular protection from stress, likely
due to increased basal intracellular HSP content and appears
directly related to the degree of physiological heat acclimation
(lower core temperature), thus the adapted individual/cell
experiences lesser relative stress at the same absolute temperature
(McClung et al., 2008).
The notion of individual differences in the responses to
local heat therapy has been highlighted in a study observing
that 24 h following 40 min of heat treatment (diathermy
followed by heat packs), female subjects significantly increased
HSP70 (+58%) and phosphorylation of HSP27 (+100%)
content compared to the untreated leg (Touchberry et al.,
2007). In comparison, male subjects had non-significant
increases in HSP70 (+35%) and HSP27 phosphorylation
(+32%) within skeletal muscle (Touchberry et al., 2007).
These sex-specific responses are intriguing and warrant
future investigation given no differences in Hsp70 mRNA
have been reported during isothermic heat acclimation
(Mee et al., 2016) and were not reported in the mixed-
sex cohort undertaking passive heating described above
(Kuhlenhoelter et al., 2016).
Central and Peripheral Effects of Body
Warming
The administration of heat therapy and heat acclimation may
provide additional benefits in the context of neurodegenerative
diseases in relation to skeletal muscle function, cerebral blood
flow, and metabolic health. Adverse reductions in strength and
lean body mass are symptoms of neurodegenerative diseases,
including Alzheimer’s disease (Burns et al., 2010; Buchman and
Bennett, 2011), Parkinson’s disease (Berardelli et al., 2001; Petroni
et al., 2003; Cano-de-la-Cuerda et al., 2010) and Amyotrophic
Lateral Sclerosis (Gubbay et al., 1985; Munsat et al., 1988;
Kiernan et al., 2011). While various mechanisms are at play,
muscle atrophy and decreased strength likely owe to symptom-
influenced reductions in physical activity, along with central and
peripheral nervous system changes that limit muscle activation
(Hass et al., 2007). Furthermore, reduced cerebral blood flow
and poor metabolic health profiles may also be related to
disease progression (de la Torre, 2004; Akinyemi et al., 2013;
Bharadwaj et al., 2017; Sweeney et al., 2018). As there is a
potential benefit to be gained, the below reviews the current
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developing understanding of the acute and chronic effects of
elevated temperature on skeletal muscle function, cerebral blood
flow, and markers of metabolic health.
Skeletal Muscle Function
Increases in skeletal muscle temperature have long been accepted
to improve acute muscle force, power and contractility (Bergh
and Ekblom, 1979; Davies and Young, 1983; Bennett, 1984).
Contrastingly, the inverse relationship between high core body
temperature and muscle torque, muscle recruitment patterns,
and voluntary activation is also documented (Morrison et al.,
2004; Todd et al., 2005; Thomas et al., 2006). Importantly,
however, these outcomes are most often viewed with a short-
term lens, with limited understanding of the effects of time or
repeated heat exposures on skeletal muscle in humans (Brazaitis
and Skurvydas, 2010; Goto et al., 2011; Racinais et al., 2017).
Passive heating has been reported in experimental designs
examining effects on exercise-induced muscle damage (Nosaka
et al., 2007; Touchberry et al., 2012), recovery from muscle injury
(Kojima et al., 2007; Oishi et al., 2009; Takeuchi et al., 2014)
and immobilization (Selsby and Dodd, 2005; Senf et al., 2008;
Dodd et al., 2009), and muscle hypertrophy (Uehara et al., 2004;
Ohno et al., 2010) in animal models. The rationale for passive
heat application relates to the altered cascade of inflammation
and HSP expression that interact with mitochondrial biogenesis
and muscle growth (Yoshihara et al., 2013; McGorm et al., 2018).
Increases in wet muscle mass and protein content in rat soleus
muscle have been described 7 days after a 60 min exposure
to a 41–42◦C heat chamber (Uehara et al., 2004; Ohno et al.,
2010). Further, Kodesh and Horowitz (2010) observed higher
muscle mass/body weight ratios in rats following 30 days of
acclimation to 34◦C environmental heat compared to a 24◦C
control. Similarly, in healthy men, Goto et al. (2011) saw an
increased cross-sectional area of fibers in the vastus lateralis
(8.3%) using a steam-generating sheet applied to the quadriceps
muscle for 8 h·day−1 and 4 days·week−1 across a 10-week
intervention. Collectively, it might be concluded that passive
heating could support cell proliferation and facilitate muscle
hypertrophy (Naito et al., 2000; Goto et al., 2004; Uehara et al.,
2004). Such outcomes would be particularly beneficial to those
experiencing neurodegenerative disease, particularly as passive
heating appears also to attenuate human skeletal muscle atrophy
(Hafen et al., 2019).
Most pertinent from a translational perspective, improved
strength has been demonstrated to couple the increased skeletal
muscle growth after passive heating (Goto et al., 2011; Racinais
et al., 2017). Higher isometric knee extensor torque (5.8%)
was achieved after 10 weeks of heat stress, which the authors
explained as potentially relating to the increase of myonuclear
number (Goto et al., 2011). Goto et al. (2011) also found a
4% increase in knee extensor strength in the non-heated leg.
While the contralateral effects of unilateral resistance training are
acknowledged (Lee and Carroll, 2007; Frazer et al., 2018), this
phenomenon may imply that there are central nervous system
effects of chronic passive heating. A potential role of circulating
factors has also been proposed (Hendy and Lamon, 2017). The
site(s) of possible neural adaptation explaining cross-education
remain unclear. However, it is conceivable that adaptations could
occur at the spinal and/or cortical level considering the noted
decline in descending motor drive during acute episodes of
hyperthermia (Todd et al., 2005; Périard et al., 2012; Ross et al.,
2012). It seems that higher body temperature acutely impairs
somatosensory processing (Nakata et al., 2015), though how
adaptation to passive heating might affect neural activity in
healthy or diseased states in thermoneutral conditions remains
to be elucidated. Regardless, adaptation to passive heat therapy is
promising, particularly in a rehabilitation setting and for those
with neurodegenerative diseases, as acute stress may increase
motor cortex excitability and augment motor skill acquisition
(Littmann and Shields, 2016).
Cerebral Blood Flow
Another avenue by which passive heating may have a therapeutic
effect is through improved cerebral blood flow. Reduced cerebral
blood flow and dysfunction in the blood-brain barrier have been
identified in neurodegenerative diseases, including Alzheimer’s
and Parkinson’s (de la Torre, 2004; Akinyemi et al., 2013;
Sweeney et al., 2018). Both motor and cognitive impairments
have been associated with poor perfusion in several brain regions
in Parkinson’s disease (Melzer et al., 2011). Similarly, overall and
regional cerebral blood flow reductions have been associated with
cognitive decline in mild cognitive impairment and Alzheimer’s
disease (Leeuwis et al., 2017). For these reasons, the vasculature
supplying blood to and across the brain are also relevant targets
to examine the beneficial adaptations of passive heat therapy for
neurodegenerative diseases.
Several vascular adaptations attributable to heat therapy have
been reported. These have included improved flow-mediated
dilation (Brunt et al., 2016a), increased pulse wave velocity (an
index of arterial stiffness) (Brunt et al., 2016a), reduced carotid
intima thickness (Brunt et al., 2016a) improved capillarization
(Hesketh et al., 2019) and subsequently enhanced systemic
blood pressure profiles (Brunt et al., 2016a; Akerman et al.,
2019). Mechanistically, HSP27 has been shown to reduce
intimal hyperplasia (Connolly et al., 2003), with greater carotid
intima thickness associated with reduced cerebral blood flow
(Sojkova et al., 2010). Undesirable vascular hypertrophy can
also be mitigated against via HSP70 associated inhibition of
Angiotension II (Zheng et al., 2006), with HSP90 conferring
a more general adaptation aligned to the stabilization of the
vascular endothelial growth factor (VEGF) upstream target
hypoxia-inducible factor-1 (HIF-1α) (Maloyan et al., 2005),
and elevated endothelial nitric oxide production and improved
the stabilization and bioavailability of endothelial nitric oxide
synthase (Averna et al., 2008). Collectively these vascular
adaptations observed in passive heating interventions have the
potential to maintain cerebral blood flow and blood-brain
barrier function, outcomes which may have beneficial effects for
cognitive function in Alzheimer’s and Parkinson’s diseases.
Metabolic Health
Markers of metabolic health may also play a role in the
pathogenesis of neurodegeneration in Alzheimer’s disease. The
neurodegeneration seen in Alzheimer’s disease has been linked
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FIGURE 1 | Potential benefits arising from heat therapy for people with
neurodegenerative disease (↑ symbolizes an increasing effect; ↓ symbolizes a
decreasing effect).
with impaired cerebral insulin signaling and glucose metabolism
(Bharadwaj et al., 2017). The loss of protein homeostasis
(Aβ accumulation and tau hyperphosphorylation), synaptic
degeneration, and neural dysfunction have been associated with
these impairments to normal metabolic processes (Bharadwaj
et al., 2017). Recent research has therefore proposed therapeutic
interventions to improve insulin signaling and reduce insulin
resistance. Interestingly, heat therapy has been proposed for
people with type II diabetes, and early studies have highlighted a
reduction in fasting plasma glucose following repeated hot water
bath immersions over 3 weeks (Hooper, 1999). Furthermore,
chronic heat therapy interventions have improved glucose
tolerance and insulin sensitivity in women with polycystic ovary
syndrome who experience obesity and metabolic dysfunction
(Ely et al., 2019). Therefore, the effects of heat therapy on
metabolic health are another potential avenue of therapeutic
benefit for people with neurodegenerative disease.
Summary
For individuals who do not experience these important
physiological stressors through habitual activity and exercise,
heat therapy may provide a vehicle to achieve a range of health
and physiological benefits (Figure 1). Much remains to be
understood with regards to the mechanisms and stimuli required
to elicit the desired increases in relevant HSPs following heat
therapy, in addition to further quantifying the magnitude of
importance of these responses. Additionally, the potential to
improve muscular function, cerebral blood flow, and markers
of metabolic health offer significant benefit for people with a
neurodegenerative disease by improving their quality of life
and reducing disease severity. Part of the present ambiguity
results from the utilization of different methods, e.g., heating
technique, heating duration and magnitude, tissue sample site
and time points, across experimental studies. Despite the need
for further clarity regarding the mechanistic underpinnings and
best practice implementation, the opportunities to investigate a
tolerable heat therapy model in a relevant target population exists
and should be encouraged.
BODY WARMING IN PEOPLE WITH
NEURODEGENERATIVE DISEASES
Evidence for a Potential Benefit
At present, the authors are not aware of any studies that have
directly assessed the effects of active or passive body warming
on HSP release, and disease severity or progression, in people
with neurodegenerative diseases. Therefore, this review will draw
on findings from epidemiological studies, and indirect studies
of other interventions such as exercise, that have shown benefits
among people with neurodegenerative diseases.
Habitual body warming, through sauna bathing or
exercise, has been shown to reduce the risk of developing
neurodegenerative diseases. Regular passive heating has been
associated with a reduced risk of developing neurodegenerative
diseases, including Alzheimer’s (Heinonen and Laukkanen,
2018). Men participating in sauna bathing 2–3 or 4–7 times
per week had a 0.80 and 0.35 hazard ratio for developing
Alzheimer’s disease compared to men who sauna once per
week or less (Laukkanen et al., 2017). Regular exercise also
has a protective effect on the risk of developing Alzheimer’s
and Parkinson’s diseases (Paillard et al., 2015). Consistent and
frequent participation in moderate to vigorous physical activity
was found to reduce the risk of Parkinson’s disease by up to 40%
(Xu et al., 2010). Similarly, exercising three or more times per
week is associated with a lower incidence rate of dementia and
Alzheimer’s (Larson et al., 2006). While these studies do not
elucidate the potential mechanisms by which a protective effect
is elicited, it does lend anecdotal evidence toward the expression
of HSP through regular body warming as a distinct possibility.
Further to a preventative effect, exercise has been described
as having a restorative effect on the neurodegeneration observed
in Alzheimer’s and Parkinson’s diseases (Loprinzi et al., 2013;
Paillard et al., 2015). Clinical and epidemiological studies have
provided evidence supporting the conclusion that exercise has
therapeutic value by reducing the symptoms and slowing disease
progression (Ransmayr, 2011; Hou et al., 2017; Liu et al., 2019).
Moderate to high-intensity aerobic exercises, such as treadmill
walking or assisted cycling, are recommended for improved
motor and cognitive function in Parkinson’s disease (Ahlskog,
2011; Salgado et al., 2013; Evens and Clark, 2017). High-intensity
treadmill exercise of 30 min at a target heart rate prevented
Parkinson’s disease progression, compared to moderate intensity
and control (Schenkman et al., 2018). Furthermore, interval
exercises (alternating periods of low and high intensity assisted
cycling) have shown positive improvements in functional ability
in Parkinson’s patients (Uygur et al., 2015, 2017). Immersion
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in warm water (33◦C) for 50 min while performing dual-
task exercises (combining physical movements with cognitive
tasks) was found to improve functional mobility (timed
up and go, and five-time sit-to-stand) among people with
Parkinson’s disease following 3 months of twice-weekly exposures
(Silva and Israel, 2019).
Exercise interventions have also had significant effects on
slowing the progression of Alzheimer’s disease. Over 1 year,
people with Alzheimer’s disease who participated in twice-
weekly 1-h exercise sessions showed reduced rates of decline in
measures of functional independence and physical performance,
compared to control participants (Pitkala et al., 2013). In a
similar intervention, the ability to perform activities of daily
living declined significantly slower in people with Alzheimer’s
disease performing twice-weekly exercise programs (Rolland
et al., 2007). A 6-month walking program has also shown people
with Alzheimer’s disease to be able to maintain cognitive function
on the Mini Mental State Exam (MMSE), compared to significant
declines in those not exercising (Venturelli et al., 2011). Overall,
there is compelling evidence that exercise improves motor
and cognitive function in neurodegenerative disease and it is
therefore recommended by clinicians (Ransmayr, 2011; Hou
et al., 2017; Liu et al., 2019). However, exercise and body warming
interventions should consider the difficulties in performing such
activities for these populations (section “Considerations for Heat
Therapy for People With Neurodegenerative Disease”).
The studies of moderate to high-intensity exercise among
neurodegenerative disease populations provide circumstantial
evidence that the assumed body warming experienced may be
contributing to the beneficial effects observed. While there may
be many avenues by which exercise and body warming promote
improved health and function, the role of body temperature
elevation, thermoregulatory responses, and HSP expression have
been overlooked in these experiments. Given the growing body
of evidence that supports the expression of HSPs as therapeutic
targets for Alzheimer’s and Parkinson’s diseases (section “Heat
Shock Proteins As a Therapeutic Target”), there is a clear
need for future investigations of passive heating to monitor
thermoregulation and HSP responses in people with these
neurodegenerative diseases.
Considerations for Heat Therapy for
People With Neurodegenerative Disease
An important consideration in conducting heat acclimation and
heat therapy for older adults and clinical populations will be
how their impairments or any co-morbidities may affect their
ability to perform and tolerate these interventions. Firstly, their
disease severity may impair their physical ability to perform
movements effectively and safely (Kerr et al., 2010; Buchman
and Bennett, 2011). Secondly, neurodegeneration may cause
deficits in thermoregulatory processes. In Parkinson’s disease,
neural degeneration in higher-order brain centers including the
hypothalamus is associated with impaired sudomotor function
which in turn may influence their tolerance to body warming
(LeDoux, 2013).
Neurodegenerative diseases such as Parkinson’s and Motor
Neuron Disease primarily affect motor control. As the diseases
progress, motor function deteriorates resulting in impaired gait
and balance and an increased risk of falls (Pickering et al.,
2007). While Alzheimer’s is usually associated with cognitive
impairments, significant motor impairments are also associated
with this disease (Buchman and Bennett, 2011). Therefore,
exercise and heat acclimation interventions should consider the
level of impairment of their target population and how the risk of
falls and injury may be managed. As such, in these populations
where movement is limited, passive heat therapy may be an
achievable alternative to exercise interventions.
The autonomic nervous system, responsible for
thermoregulation, can exhibit deficits in neurodegenerative
diseases, specifically in the thermoeffector responses of sweating
and skin blood flow. Abnormalities in the sweating response,
hyperhidrosis and/or hypohidrosis, are commonly reported
in Parkinson’s disease (De Marinis et al., 1991; Swinn et al.,
2003; Schestatsky et al., 2006) and may be more prominent
with increasing age and disease severity of patients (Saito and
Kogure, 1989). Hypohidrosis, an absence of the sweating or
reduced sweat output, may reduce effective body cooling during
exercise and body warming. However, the sweating response is
highly individualized, and compromised sweating in one body
region may be compensated by increased sweating in other
body regions (Schestatsky et al., 2006). Careful attention should,
therefore, be given to the rate of body warming people with
Parkinson’s disease may experience, and ensuring appropriate
cooling strategies are available.
Cardiovascular regulation of blood pressure is also influenced
by neurodegenerative disease. The expected elevation in heart
rate and blood pressure may be blunted in people with
Parkinson’s disease, and they may also experience post-exercise
hypotension (Asahina et al., 2013). Orthostatic intolerance is
also reported in 10–60% of people with Parkinson’s disease
(Senard et al., 1997; Wüllner et al., 2007). These cardiovascular
impairments may influence their ability to tolerate exercise
and body warming and should be considered in determining
individual suitability for heat therapy and heat acclimation.
The modality of passive heating may therefore also be
an important factor in determining appropriate therapeutic
techniques. Infrared sauna bathing has been reported to promote
lower cardiovascular strain than traditional sauna techniques
(Mero et al., 2015) and may be one avenue that could be
investigated for suitability in these at-risk populations.
FUTURE DIRECTIONS
Overall, there are three key points from the scientific literature
that support a proposal for a therapeutic effect of heat therapy
or heat acclimation to promote HSP expression in people with
neurodegenerative disease. These include, (1) Exercise, sufficient
to raise core body temperature, is currently recommended for
people with neurodegenerative disease (e.g., Parkinson’s and
Alzheimer’s diseases) as it has been shown to improve their
symptoms; (2) Elevated HSP levels have been identified as a
therapeutic target to reduce protein aggregation and toxicity; and
(3) Exercise and body warming have been shown to elevate HSP
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expression in healthy adults. Furthermore, heat therapy may have
additional benefits for muscle function, vasculature health and
cerebral blood flow, and indicators of metabolic health, which
have also been implicated in the pathophysiological presentation
of neurodegenerative diseases. These findings from the current
scientific literature support the proposal for further investigation
into the potentially beneficial adaptations for people with
neurodegenerative diseases to heat therapy and heat acclimation.
Initial research is required to establish the acute
effects of heat therapy and/or heat acclimation in people
with neurodegenerative diseases. As these diseases may
involve impairment of autonomic pathways involved in
thermoregulation, research is required to elucidate the
thermoeffector responses, sweating and skin blood flow, to
acute heat stress and how these may affect tolerance to
body warming. Alongside these outcomes HSP expression,
muscular adaptations, and vasculature function responses
to body warming should be measured in neurodegenerative
disease populations, to determine the presence of a similar
response to body warming as seen in healthy adults, and
the magnitude of the response in relation to the tolerable
limits of body warming. Consequent to acute observations
that tolerable heat exposures promote the desirable HSP
response and vascular adaptations, further investigation should
then pursue the effects of chronic or repeated heat therapy
and/or heat acclimation on these responses and indicators of
disease severity and progression. Finally, an understanding
of the dose-response relationship between frequency and
intensity of body warming and improved symptomology
should be determined. In concert with these research efforts,
investigations of the underlying mechanisms by which HSP
expression and body warming may improve neuromuscular
function are warranted.
CONCLUSION
While the current evidence for heat therapy in neurodegenerative
disease is associative and the mechanisms of improved
health outcomes have yet to be elucidated, the potential
of passive heating in this population remains an alluring
therapeutic option. Heat acclimation and heat therapy
have been shown to improve HSP responses in healthy
adults, as well as induce additional benefits for skeletal
muscle function and cerebral blood flow. Furthermore,
HSPs have been identified as therapeutic targets to restore
protein homeostasis and reduce protein toxicity in several
neurodegenerative diseases. While circumstantial evidence
exists that body warming may promote improved health and
function in neurodegenerative disease, through exercise or
sauna bathing, there is yet to be any direct studies of body
warming, thermal tolerance, and HSP responses in these
populations. For individuals who do not experience these
important physiological stressors through habitual activity
and exercise, heat therapy may provide a vehicle to achieve
improved health and slowed disease progression in people
with neurodegenerative disease, and, therefore, warrants
further investigation.
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